Speakers
INHSU 2024 will feature over 100+ sessions on epidemiology and public health research, clinical research, social science and policy research, and good practice models of care for people who use drugs.
Keynote speakers
Professor Alison Ritter, DPMP (Drug Policy Modelling Program)
UNSW Sydney, Australia
Presenting: Drug Policy Reform:
Evaluation of decriminalisation and regulation models
Dr. Thomas Kerr
The University of British Columbia, Canada
Presenting:
Safer supply: A critical review of different models and their impact.
Matt Southwell, EuroNPUD, UK
Presenting:
Innovation in NSP programming: what works and what’s coming
Dr. Nadine Kronfli, McGill University, Canada
Presenting:
Global Picture of Harm Reduction Programming in Prisons.
Invited speakers
Dr. Saeed Hamid, The Aga Khan University, Pakistan
Presenting: Innovations in testing for HCV
Sarah Larney, Université de Montréal, Canada
Presenting: Addressing gender disparities in HCV testing and treatment uptake: Providing gender responsive models of care
Dr. Julie Bruneau
Université de Montréal, Canada
Presenting: Clinical considerations for opioid agonist treatment (OAT) selection and delivery
Charles Henderson
Burnet Institute, Melbourne, Australia
Presenting: Understanding patient preferences and decision-making for opioid agonist therapies
George Papatheodoridis
Athens Medical School and Laiko Hospital, Athens, Greece
Presenting: Innovations in therapeutic developments for HBV and HDV
Dr. Joshua Barocas, University of Colorado School of Medicine, oThe Missing US Lab Project, Social Determinants of Health and Disparities Modeling Unit, USA
Presenting: Future therapies for skin and soft tissue infections in people who inject drugs
Dr. Vana Sypsa
National and Kapodistrian University of Athens
Presenting: HCV elimination progress in people who inject drugs